1. Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications
    Gökçe Şeker Karatoprak et al, 2020, Molecules CrossRef
  2. Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents
    Nitesh Sanghai et al, 2014, Med. Chem. Commun. CrossRef
  3. Recent Advances in β-lactam Derivatives as Potential Anticancer Agents
    Xinfen Zhang et al, 2020, Current Topics in Medicinal Chemistry CrossRef
  4. Plants of the genus Terminalia: Phytochemical and antioxidant profiles, proliferation, and cancer
    Ian Edwin Cock et al, 2021, Cancer CrossRef
  5. Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players
    Shazia Ali et al, 2016, Frontiers in Oncology CrossRef
  6. Effect of CPU-XT-008, a combretastatin A-4 analogue, on the proliferation, apoptosis and expression of vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein endothelial cells
    RUI XIONG et al, 2016, Oncology Letters CrossRef
  7. Combretastatins: More Than Just Vascular Targeting Agents?
    Lisa M. Greene et al, 2015, Journal of Pharmacology and Experimental Therapeutics CrossRef
  8. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4
    Azizah M. Malebari et al, 2021, Pharmaceuticals CrossRef
  9. Harnessing the Properties of Natural Products
    Asmaa Boufridi et al, 2018, Annual Review of Pharmacology and Toxicology CrossRef
  10. β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells
    Azizah M. Malebari et al, 2020, European Journal of Medicinal Chemistry CrossRef
  11. 3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells
    null Wang et al, 2019, Pharmaceuticals CrossRef
  12. Tetrazoles for biomedicine
    Elena A. Popova et al, 2019, Russian Chemical Reviews CrossRef
  13. Combretastatin (CA)-4 and its novel analogue CA-432 impair T-cell migration through the Rho/ROCK signalling pathway
    Jade K. Pollock et al, 2014, Biochemical Pharmacology CrossRef
  14. Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells
    Jade K. Pollock et al, 2018, Investigational New Drugs CrossRef
  15. Insights into drug discovery from natural products through structural modification
    Jichao Chen et al, 2015, Fitoterapia CrossRef
  16. Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer
    Chatla Srinivas et al, 2015, PLOS ONE CrossRef
  17. A Brief Review on the Development of Novel Potentially Active Azetidin-2-ones Against Cancer
    Ligia S. da Silveira Pinto et al, 2020, Current Organic Chemistry CrossRef
  18. Antiangiogenic activity of the penicillin derivative TAP7f in melanoma
    Elizabeth Barrionuevo et al, 2023, Journal of Molecular Medicine CrossRef